396 related articles for article (PubMed ID: 18510103)
1. Fragment-based drug discovery using rational design.
Jhoti H
Ernst Schering Found Symp Proc; 2007; (3):169-85. PubMed ID: 18510103
[TBL] [Abstract][Full Text] [Related]
2. Counting on Fragment Based Drug Design Approach for Drug Discovery.
Kashyap A; Singh PK; Silakari O
Curr Top Med Chem; 2018; 18(27):2284-2293. PubMed ID: 30499406
[TBL] [Abstract][Full Text] [Related]
3. Fragments: where are we now?
Osborne J; Panova S; Rapti M; Urushima T; Jhoti H
Biochem Soc Trans; 2020 Feb; 48(1):271-280. PubMed ID: 31985743
[TBL] [Abstract][Full Text] [Related]
4. Fragment-based drug design.
Feyfant E; Cross JB; Paris K; Tsao DH
Methods Mol Biol; 2011; 685():241-52. PubMed ID: 20981527
[TBL] [Abstract][Full Text] [Related]
5. The rise of fragment-based drug discovery.
Murray CW; Rees DC
Nat Chem; 2009 Jun; 1(3):187-92. PubMed ID: 21378847
[TBL] [Abstract][Full Text] [Related]
6. Fragment-based drug design: computational & experimental state of the art.
Hoffer L; Renaud JP; Horvath D
Comb Chem High Throughput Screen; 2011 Jul; 14(6):500-20. PubMed ID: 21521152
[TBL] [Abstract][Full Text] [Related]
7. Fragment-based drug discovery and its application to challenging drug targets.
Price AJ; Howard S; Cons BD
Essays Biochem; 2017 Nov; 61(5):475-484. PubMed ID: 29118094
[TBL] [Abstract][Full Text] [Related]
8. Electron density guided fragment-based drug design--a lead generation example.
Abad MC; Gibbs AC; Zhang X
Methods Enzymol; 2011; 493():487-508. PubMed ID: 21371603
[TBL] [Abstract][Full Text] [Related]
9. Medicinal chemistry inspired fragment-based drug discovery.
Lanter J; Zhang X; Sui Z
Methods Enzymol; 2011; 493():421-45. PubMed ID: 21371600
[TBL] [Abstract][Full Text] [Related]
10. Effective progression of nuclear magnetic resonance-detected fragment hits.
Eaton HL; Wyss DF
Methods Enzymol; 2011; 493():447-68. PubMed ID: 21371601
[TBL] [Abstract][Full Text] [Related]
11. A three-stage biophysical screening cascade for fragment-based drug discovery.
Mashalidis EH; Śledź P; Lang S; Abell C
Nat Protoc; 2013 Nov; 8(11):2309-24. PubMed ID: 24157549
[TBL] [Abstract][Full Text] [Related]
12. From small to powerful: the fragments universe and its "chem-appeal".
Sancineto L; Massari S; Iraci N; Tabarrini O
Curr Med Chem; 2013; 20(11):1355-81. PubMed ID: 23410157
[TBL] [Abstract][Full Text] [Related]
13. Practical aspects of NMR-based fragment discovery.
Zartler ER; Mo H
Curr Top Med Chem; 2007; 7(16):1592-9. PubMed ID: 17979770
[TBL] [Abstract][Full Text] [Related]
14. Fragment screening for drug leads by weak affinity chromatography (WAC-MS).
Ohlson S; Duong-Thi MD
Methods; 2018 Aug; 146():26-38. PubMed ID: 29378316
[TBL] [Abstract][Full Text] [Related]
15. Fragment informatics and computational fragment-based drug design: an overview and update.
Sheng C; Zhang W
Med Res Rev; 2013 May; 33(3):554-98. PubMed ID: 22430881
[TBL] [Abstract][Full Text] [Related]
16. Protein X-ray Crystallography and Drug Discovery.
Maveyraud L; Mourey L
Molecules; 2020 Feb; 25(5):. PubMed ID: 32106588
[TBL] [Abstract][Full Text] [Related]
17. Design Principles for Fragment Libraries: Maximizing the Value of Learnings from Pharma Fragment-Based Drug Discovery (FBDD) Programs for Use in Academia.
Keserű GM; Erlanson DA; Ferenczy GG; Hann MM; Murray CW; Pickett SD
J Med Chem; 2016 Sep; 59(18):8189-206. PubMed ID: 27124799
[TBL] [Abstract][Full Text] [Related]
18. Hit triage using efficiency indices after screening of compound libraries in drug discovery.
Reitz AB; Smith GR; Tounge BA; Reynolds CH
Curr Top Med Chem; 2009; 9(18):1718-24. PubMed ID: 19929837
[TBL] [Abstract][Full Text] [Related]
19. NMR screening in fragment-based drug design: a practical guide.
Kim HY; Wyss DF
Methods Mol Biol; 2015; 1263():197-208. PubMed ID: 25618347
[TBL] [Abstract][Full Text] [Related]
20. The benefits of constructing leads from fragment hits.
Foloppe N
Future Med Chem; 2011 Jul; 3(9):1111-5. PubMed ID: 21806375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
